Author Correction: Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus (BMC Biology, (2022), 20, 1, (222), 10.1186/s12915-022-01410-3)

Shi Hao Lee; Chew Leng Lim; Wei Shen; Samuel Ming Xuan Tan; Amanda Rui En Woo; Yeannie H.Y. Yap; Caitlyn Ang Su Sian; Wilson Wen Bin Goh; Wei Ping Yu; Li Li; Valerie C.L. Lin

doi:10.1186/s12915-023-01543-z

Author Correction: Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus (BMC Biology, (2022), 20, 1, (222), 10.1186/s12915-022-01410-3)

Shi Hao Lee, Chew Leng Lim, Wei Shen, Samuel Ming Xuan Tan, Amanda Rui En Woo, Yeannie H.Y. Yap, Caitlyn Ang Su Sian, Wilson Wen Bin Goh, Wei Ping Yu, Li Li^*, Valerie C.L. Lin^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The original article [1] contains two incorrect terms in the following sentence: “We propose that the antioestrogenic effect of PGR at certain developmental stage (e.g. GD 2–3) is achieved by genomic upregulation of Esr1 and its coactivator Greb1 which in turn enhance the expression of other oestrogen target genes." In the aforementioned sentence, ’upregulation’ should instead be ’downregulation’, and ’enhance’ should instead be ’reduce’, yielding the following, correct sentence: “We propose that the antioestrogenic effect of PGR at certain developmental stage (e.g. GD 2–3) is achieved by genomic downregulation of Esr1 and its coactivator Greb1 which in turn reduce the expression of other oestrogen target genes."

Original language	English
Article number	34
Journal	BMC Biology
Volume	21
Issue number	1
DOIs	https://doi.org/10.1186/s12915-023-01543-z
Publication status	Published - Dec 2023
Externally published	Yes

Bibliographical note

Publisher Copyright:
© The Author(s) 2023.

ASJC Scopus Subject Areas

Biotechnology
Structural Biology
Ecology, Evolution, Behavior and Systematics
Physiology
General Biochemistry,Genetics and Molecular Biology
General Agricultural and Biological Sciences
Plant Science
Developmental Biology
Cell Biology

Access to Document

10.1186/s12915-023-01543-z

Cite this

Lee, S. H., Lim, C. L., Shen, W., Tan, S. M. X., Woo, A. R. E., Yap, Y. H. Y., Sian, C. A. S., Goh, W. W. B., Yu, W. P., Li, L., & Lin, V. C. L. (2023). Author Correction: Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus (BMC Biology, (2022), 20, 1, (222), 10.1186/s12915-022-01410-3). BMC Biology, 21(1), Article 34. https://doi.org/10.1186/s12915-023-01543-z

@article{a700bd6604144ed197f1bc734eb3a523,

title = "Author Correction: Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus (BMC Biology, (2022), 20, 1, (222), 10.1186/s12915-022-01410-3)",

abstract = "The original article [1] contains two incorrect terms in the following sentence: “We propose that the antioestrogenic effect of PGR at certain developmental stage (e.g. GD 2–3) is achieved by genomic upregulation of Esr1 and its coactivator Greb1 which in turn enhance the expression of other oestrogen target genes.{"} In the aforementioned sentence, {\textquoteright}upregulation{\textquoteright} should instead be {\textquoteright}downregulation{\textquoteright}, and {\textquoteright}enhance{\textquoteright} should instead be {\textquoteright}reduce{\textquoteright}, yielding the following, correct sentence: “We propose that the antioestrogenic effect of PGR at certain developmental stage (e.g. GD 2–3) is achieved by genomic downregulation of Esr1 and its coactivator Greb1 which in turn reduce the expression of other oestrogen target genes.{"}",

author = "Lee, {Shi Hao} and Lim, {Chew Leng} and Wei Shen and Tan, {Samuel Ming Xuan} and Woo, {Amanda Rui En} and Yap, {Yeannie H.Y.} and Sian, {Caitlyn Ang Su} and Goh, {Wilson Wen Bin} and Yu, {Wei Ping} and Li Li and Lin, {Valerie C.L.}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2023.",

year = "2023",

month = dec,

doi = "10.1186/s12915-023-01543-z",

language = "English",

volume = "21",

journal = "BMC Biology",

issn = "1741-7007",

publisher = "BioMed Central",

number = "1",

}

Lee, SH, Lim, CL, Shen, W, Tan, SMX, Woo, ARE, Yap, YHY, Sian, CAS, Goh, WWB, Yu, WP, Li, L & Lin, VCL 2023, 'Author Correction: Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus (BMC Biology, (2022), 20, 1, (222), 10.1186/s12915-022-01410-3)', BMC Biology, vol. 21, no. 1, 34. https://doi.org/10.1186/s12915-023-01543-z

Author Correction: Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus (BMC Biology, (2022), 20, 1, (222), 10.1186/s12915-022-01410-3). / Lee, Shi Hao; Lim, Chew Leng; Shen, Wei et al.
In: BMC Biology, Vol. 21, No. 1, 34, 12.2023.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Author Correction

T2 - Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus (BMC Biology, (2022), 20, 1, (222), 10.1186/s12915-022-01410-3)

AU - Lee, Shi Hao

AU - Lim, Chew Leng

AU - Shen, Wei

AU - Tan, Samuel Ming Xuan

AU - Woo, Amanda Rui En

AU - Yap, Yeannie H.Y.

AU - Sian, Caitlyn Ang Su

AU - Goh, Wilson Wen Bin

AU - Yu, Wei Ping

AU - Li, Li

AU - Lin, Valerie C.L.

PY - 2023/12

Y1 - 2023/12

N2 - The original article [1] contains two incorrect terms in the following sentence: “We propose that the antioestrogenic effect of PGR at certain developmental stage (e.g. GD 2–3) is achieved by genomic upregulation of Esr1 and its coactivator Greb1 which in turn enhance the expression of other oestrogen target genes." In the aforementioned sentence, ’upregulation’ should instead be ’downregulation’, and ’enhance’ should instead be ’reduce’, yielding the following, correct sentence: “We propose that the antioestrogenic effect of PGR at certain developmental stage (e.g. GD 2–3) is achieved by genomic downregulation of Esr1 and its coactivator Greb1 which in turn reduce the expression of other oestrogen target genes."

AB - The original article [1] contains two incorrect terms in the following sentence: “We propose that the antioestrogenic effect of PGR at certain developmental stage (e.g. GD 2–3) is achieved by genomic upregulation of Esr1 and its coactivator Greb1 which in turn enhance the expression of other oestrogen target genes." In the aforementioned sentence, ’upregulation’ should instead be ’downregulation’, and ’enhance’ should instead be ’reduce’, yielding the following, correct sentence: “We propose that the antioestrogenic effect of PGR at certain developmental stage (e.g. GD 2–3) is achieved by genomic downregulation of Esr1 and its coactivator Greb1 which in turn reduce the expression of other oestrogen target genes."

UR - http://www.scopus.com/inward/record.url?scp=85148252681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85148252681&partnerID=8YFLogxK

U2 - 10.1186/s12915-023-01543-z

DO - 10.1186/s12915-023-01543-z

M3 - Comment/debate

C2 - 36797738

AN - SCOPUS:85148252681

SN - 1741-7007

VL - 21

JO - BMC Biology

JF - BMC Biology

IS - 1

M1 - 34

ER -

Author Correction: Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus (BMC Biology, (2022), 20, 1, (222), 10.1186/s12915-022-01410-3)

Abstract

Bibliographical note

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this